U.S. markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
125.83+1.12 (+0.90%)
At close: 04:02PM EST
125.73 -0.10 (-0.08%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close124.71
Bid125.43 x 1300
Ask125.87 x 800
Day's Range124.86 - 127.09
52 Week Range105.36 - 142.60
Avg. Volume5,515,785
Market Cap222.504B
Beta (5Y Monthly)0.70
PE Ratio (TTM)31.22
EPS (TTM)4.03
Earnings DateJan 26, 2022
Forward Dividend & Yield1.88 (1.49%)
Ex-Dividend DateJan 13, 2022
1y Target Est145.18
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-6% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Abbott Laboratories
    Weekly Stock ListThis is among our most-important themes for 2022, and stretches across industries. We think companies that raise their dividends consistently at a double-digit rate are sending off three important signals amid all the recent market volatility: 1) the company's balance sheet is strong enough to pay a dividend; 2) management is focused on providing shareholder returns; and 3) management is confident enough in the near-term outlook to raise the payout aggressively. This third factor is especially important as the pandemic upends the nation's recent record of long-term economic growth. Here are 12 stocks that meet our double-digit dividend test and are on the Argus BUY list. They are also holdings in our Dividend Growth Separately Managed Account and in the Dividend Growers Total Return Trust, sponsored by SmartTrust.
    Fair Value
    Economic Moat
    12 days agoArgus Research
View more

    Harrington Investments, INC Buys Pfizer Inc, AerCap Holdings NV, Sells Chubb, Abbott ...

    Investment company Harrington Investments, INC (Current Portfolio) buys Pfizer Inc, AerCap Holdings NV, sells Chubb, Abbott Laboratories, JPMorgan Chase, Danaher Corp, Shopify Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Harrington Investments, INC.

  • Motley Fool

    3 Things About Abbott Laboratories That Smart Investors Know

    When it comes to underrated healthcare stocks that smart investors love, Abbott Laboratories (NYSE: ABT) takes the cake. On the contrary, it's exactly Abbott's willingness to compete in these spaces that makes the company one of the sturdiest. Given that Abbott has a market cap of about $238 billion and trailing revenue of $42.3 billion, it shouldn't surprise anyone that the business sometimes struggles to grow as aggressively as a smaller competitor might.

  • Zacks

    Rise in COVID-19 Test Demand to Boost Abbott (ABT) Q4 Earnings

    With the latest surge in COVID infections due to the more contagious Omicron variant, Abbott (ABT) is expected to report sequentially stronger diagnostics results for the fourth quarter.